Company Filing History:
Years Active: 2013
Title: **Kathleen Park: Innovator in Veterinary Vaccines**
Introduction
Kathleen Park is an accomplished inventor based in St. Joseph, Missouri. She has made significant contributions to veterinary medicine, specifically through her innovation in vaccine development. With a focus on providing effective immunization solutions, she stands out as an active figure in the research and development of veterinary vaccines.
Latest Patents
Kathleen holds a patent for a groundbreaking invention: a one-dose vaccination against mycoplasma infections in pigs. This innovative vaccine formulation comprises an immunizing amount of abacterin and an acrylic acid polymer, with a precise concentration range between 0.8 and 1.2 mg/ml, all delivered in a pharmaceutically acceptable carrier without any oil. This vaccine is particularly noteworthy as it ensures effective immunity in pigs for at least 20 weeks following a single administration, achieving substantial immunity within just 4 weeks of vaccination.
Career Highlights
Kathleen Park currently works for Boehringer Ingelheim Vetmedica GmbH, a leading company in veterinary pharmaceuticals. Her work focuses on developing cutting-edge solutions that enhance animal health and welfare, solidifying her reputation within the veterinary community.
Collaborations
Throughout her career, Kathleen has collaborated with various professionals in the field, including notable coworkers such as Wiliam Charles Ohnesorge and Isabelle Freiin Von Richthofen. These collaborations have enriched her research efforts and helped to advance the field of veterinary vaccines.
Conclusion
Kathleen Park's contributions to veterinary medicine exemplify her commitment to innovation. Her patent for a one-dose vaccination against mycoplasma infections demonstrates her dedication to improving animal health and welfare. As she continues her work at Boehringer Ingelheim Vetmedica GmbH, Kathleen remains a pivotal figure in the ongoing advancement of veterinary science.